1. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization
- Author
-
Kim Wong, Nicola Griggs, Elizabeth Tuck, Sarah Spiegel, Emma L. Cambridge, Antonella Galli, Sanger Mouse Genetics, Hannah Wardle-Jones, Louise van der Weyden, Anneliese O. Speak, Natasha A. Karp, Andrew D. Campbell, Martin Del Castillo Velasco-Herrera, Owen J. Sansom, Thierry Voet, Thomas Tüting, Edward Ryder, Diane Gleeson, David J. Adams, Mark J. Arends, Iain C. Macaulay, Simon Clare, and Tobias Bald
- Subjects
Male ,0301 basic medicine ,Lung Neoplasms ,Stromal cell ,T-Lymphocytes ,Lymphocyte ,Anion Transport Proteins ,Cell ,Biology ,Article ,Metastasis ,Mice ,03 medical and health sciences ,Immune system ,Cell Movement ,Sphingosine ,Cell Line, Tumor ,Lymphopenia ,Tumor Microenvironment ,medicine ,Animals ,Neoplasm Metastasis ,Tumor microenvironment ,Genome ,Multidisciplinary ,Genomics ,medicine.disease ,Killer Cells, Natural ,Disease Models, Animal ,030104 developmental biology ,Lymphatic system ,medicine.anatomical_structure ,Cell killing ,Immunology ,Cancer research ,Female ,Lysophospholipids - Abstract
Metastasis is the leading cause of death for cancer patients. This multi-stage process requires tumour cells to survive in the circulation, extravasate at distant sites, then proliferate; it involves contributions from both the tumour cell and tumour microenvironment (‘host’, which includes stromal cells and the immune system1). Studies suggest the early steps of the metastatic process are relatively efficient, with the post-extravasation regulation of tumour growth (‘colonization’) being critical in determining metastatic outcome2. Here we show the results of screening 810 mutant mouse lines using an in vivo assay to identify microenvironmental regulators of metastatic colonization. We identify 23 genes that, when disrupted in mouse, modify the ability of tumour cells to establish metastatic foci, with 19 of these genes not previously demonstrated to play a role in host control of metastasis. The largest reduction in pulmonary metastasis was observed in sphingosine-1-phosphate (S1P) transporter spinster homologue 2 (Spns2)-deficient mice. We demonstrate a novel outcome of S1P-mediated regulation of lymphocyte trafficking, whereby deletion of Spns2, either globally or in a lymphatic endothelial-specific manner, creates a circulating lymphopenia and a higher percentage of effector T cells and natural killer (NK) cells present in the lung. This allows for potent tumour cell killing, and an overall decreased metastatic burden.
- Published
- 2017
- Full Text
- View/download PDF